CASR and hypercalcemia disease: An infant with a maternally inherited mutated allele will have a more benign clinical picture than an infant with a paternally inherited mutated allele because the resulting mild maternal hypercalcemia helps to activate the mutated fetal CaSR [8] and inhibit expression PTH secretion.